Solaris - Xeno Laboratories

Buy Solaris by Xeno Labs at XSteroids. This vial is an injectable thermogenic blend carrying two actives, clenbuterol hydrochloride and yohimbine hydrochloride, at a combined 5.4 mg per ml. Below is what each component does, the reason they are combined in the first place, what a run tends to look and feel like, how such a blend is dosed, what belongs beside it in a cutting phase, what the recovery picture looks like, where the risks sit, and how the vial should be kept.

There is no approved medicine that matches this product. Neither an injectable clenbuterol preparation nor a clenbuterol and yohimbine combination is registered for human use in the United States or the European Union, and this card is therefore a research and bodybuilding item rather than a pharmacy product. The per component milligram split is not published for the line, so only the 5.4 mg per ml total is stated here.

What the Xeno Solaris Blend Is and What You Are Buying

One multi-dose vial of an oil or aqueous blend, depending on the maker's carrier, carrying clenbuterol and yohimbine together at a combined strength of 5.4 mg per ml. Clenbuterol is a beta-2 adrenergic agonist best known in medicine as a bronchodilator outside the United States, and yohimbine is an alpha-2 adrenergic antagonist extracted from the bark of the yohimbe tree. Two different receptor families, pointed at the same tissue.

The concentration is the only documented number. Blends of this type are mixed without any published per component ratio, and no independent assay of this vial has appeared, so a reader cannot work out how many micrograms of clenbuterol sit in a given draw. Treating the total as if it described the clenbuterol content would be a mistake, which is one reason the injection volume is kept small.

How Clenbuterol and Yohimbine Work Together

Clenbuterol stimulates beta-2 receptors, which raises resting metabolic rate and pushes lipolysis, and it also acts on the heart and on skeletal muscle, which is where tremor and a faster pulse come from. Yohimbine blocks alpha-2 receptors, the ones that act as a brake on fat release. Adipose tissue carries both receptor types, and the alpha-2 brake is denser in certain stubborn areas, so blocking it while stimulating the beta-2 side is the pharmacological logic of the combination.

The problem with that logic is the arithmetic of elimination. Clenbuterol has a long half life, generally quoted at 25 to 39 hours and as much as 36 to 48 hours in some references, so a dose taken today is still working tomorrow and the next day. Yohimbine clears in a matter of hours, with estimates between 15 minutes and 2.5 hours, and its oral bioavailability is variable. The two actives therefore do not rise and fall together.

What to Expect During a Solaris Run

The first sensations are cardiovascular rather than visual. A faster resting pulse, warmth, slightly shaky hands and a raised blood pressure reading are typical in the opening days, and they often ease as the body adapts to a steady exposure, only to return if the amount is increased. Appetite usually stays normal, which is convenient in a deficit.

Visible change comes from the diet, not from the vial. Fat loss arrives at the speed the calorie deficit dictates, and the blend may make the process feel easier and shift stubborn areas a little faster without changing the underlying arithmetic. Scale weight can also move from water and glycogen rather than fat, which is why measurements taken weekly in the same conditions beat daily readings.

Solaris Dosing, Volume and Injection Interval

Because the blend has no registered dose for anything, published figures do not exist and any number in circulation comes from practice. The reference points that do exist belong to the separate components: clenbuterol is used medically at 40 to 60 micrograms a day and in unauthorised athletic use at 60 to 120 micrograms, while yohimbine in research settings is usually measured in milligrams per kilogram of body weight. Neither translates cleanly into a blend injection.

What practice does say is that volumes stay small, injected into a specific site rather than in large boluses, and that the interval is driven by the long clenbuterol half life. Daily dosing accumulates, and the accumulation is what produces the strongest cardiovascular effects several days in, not on the day of the injection itself.

Stacking Solaris in a Cutting Phase

The blend suits a phase where the calorie deficit is already doing the work. Additional thermogenic products should not be piled on top of it, because the cardiac load is additive rather than complementary; the clenbuterol tablet card on this site covers the same receptor territory and pairing the two would be stacking a drug with itself. Thyroid products such as T3 and T4 belong to a separate metabolic conversation.

On the anabolic side, Testosterone Esters from Xeno Labs protect muscle while the deficit runs, and Trenbolone Esters are the harder edge of the same idea. Neither is required by the blend, and both carry their own cardiovascular effects, which is worth remembering when they are used in the same weeks.

Hormonal Recovery Around a Solaris Phase

This vial is not a steroid and does not suppress the axis by itself. Clenbuterol and yohimbine do not act on luteinising hormone or on testosterone production, so a cutting phase that uses only Solaris requires no post-cycle restart. That is the one clear advantage it has over a cutting blend built from anabolic compounds.

The picture changes when it is run beside an anabolic cycle, which is the common case. If a steroid course is in the background, the recovery work belongs to the steroids: Tamox (tamoxifen) or Clomiphene for several weeks once the esters have cleared, with blood work on both sides of the phase.

Solaris Side Effects and Cardiac Precautions

Two stimulants in one injection means the cardiovascular effects arrive together. Raised heart rate and blood pressure, palpitations, tremor of the hands, headache, dizziness and restlessness are the expected complaints, and clenbuterol's long half life keeps them going well after the last shot. Yohimbine adds anxiety and, in sensitive people, panic-like reactions, and there are published warnings about serious adverse events when it is taken at unregulated doses.

The regulatory position is uneven. Clenbuterol appears on the WADA prohibited list as an anabolic agent and is banned at all times for athletes, while yohimbine is not on that list but is not permitted for sale as a dietary supplement in the United States. Anyone with a heart condition, hypertension or an anxiety disorder is squarely outside the group this product is sold to, and the vial is supplied for research use only.

Storing the Solaris Vial

Keep the vial upright, sealed and out of light at ordinary room temperature, in a dry place away from the damp of a bathroom. Refrigeration is unnecessary for a solution of this kind and freezing will destroy it. Wipe the stopper before each draw and cap the vial immediately afterwards, check the batch code and the expiry date before first use, and discard it if the contents look cloudy or carry specks.

Why Buy Xeno Solaris from XSteroids?

Both the Solaris vial and the thermogenic and thyroid products that surround a cutting phase are shelved in the Xeno Labs catalogue on this site, so the shelf can be ordered in one step. Payment runs through an encrypted checkout and parcels leave discreetly; an American address is usually served within roughly a week, while shipments abroad need twelve to twenty-six days. The related cards below cover the products most often used in the same phase.